Medical Assistance
Receive guidance from the first consultation through the entire hospitalization process.
Receive guidance from the first consultation through the entire hospitalization process.
Medical experts assist the patients to find the right doctor and book appointments.
Consult with 5000+ doctors online and get all your health queries answered.
Kanishka Pandey
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells.
HER2-positive breast cancers are known to be more aggressive than HER2-negative breast cancers and are more likely to recur than HER2-negative breast cancer. The recurrence usually takes place within five years of treatment.
The good news is that recurrence is less likely these days than ever before. This is largely due to the latest targeted treatments. In fact, most people treated for early stage HER2-positive breast cancer don’t relapse. If your breast cancer is HR-positive, hormonal therapy may help reduce the risk of recurrence.
Your treatment plan will probably include a combination of therapies such as:
Targeted treatments (medicines like Herceptin, Kadcyla, Perjeta and Tykerb are used in this process) Once the treatment ends, you’ll still need periodic testing for signs of recurrence.